Eurofins Scientific (OTCMKTS:ERRFY) is a global leader in bioanalytical testing services, offering a broad portfolio of laboratory solutions to clients in the pharmaceutical, food, environmental, consumer products and agriculture sectors. The company’s core activities include analytical testing, method development, contract research and regulatory support, designed to ensure product safety, quality and compliance with international standards.
Founded in 1987 by Dr. Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions. Today it operates a network of more than 900 laboratories across over 50 countries, serving customers in Europe, North America, Asia-Pacific and beyond. Its service lines encompass pharmaceutical and biotech testing, food and feed testing, environmental monitoring, genomics, consumer product testing and agroscience services, enabling it to address a wide range of industry-specific analytical challenges.
Under the leadership of founder and CEO Dr. Gilles Martin, Eurofins emphasizes scientific excellence, regulatory expertise and operational efficiency. The company employs tens of thousands of scientists, technicians and support staff who work collaboratively to deliver fast turnaround times and robust data integrity. Eurofins continues to invest in new technologies and laboratory infrastructure to support its mission of improving health, safety and quality for businesses, regulators and consumers worldwide.
AI Generated. May Contain Errors.
Free ERRFY Stock Alerts